Cite
HARVARD Citation
Gargiulo, P. et al. (2019). Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores. Therapeutic advances in medical oncology. p. . [Online].